Cargando…
2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations
BACKGROUND: Enterobacter species are major nosocomial pathogens, and the clinical implications and mechanisms of colistin heteroresistance (CHR) in Enterobacter remain unclear. METHODS: We used the population analysis profile (PAP) assay to determine the presence of CHR in Enterobacter. To examine w...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678721/ http://dx.doi.org/10.1093/ofid/ofad500.1811 |
_version_ | 1785150430291951616 |
---|---|
author | Wang, Chengcheng Feng, Yu Zong, Zhiyong |
author_facet | Wang, Chengcheng Feng, Yu Zong, Zhiyong |
author_sort | Wang, Chengcheng |
collection | PubMed |
description | BACKGROUND: Enterobacter species are major nosocomial pathogens, and the clinical implications and mechanisms of colistin heteroresistance (CHR) in Enterobacter remain unclear. METHODS: We used the population analysis profile (PAP) assay to determine the presence of CHR in Enterobacter. To examine whether CHR leads to treatment failure, we conducted in vitro time-killing assays and in vivo assays using murine intra-abdominal infection models. To determine the genetic mechanism for the CHR phenotype, we conducted whole-genome sequencing and ultra-deep second-generation sequencing. A schematic outline of methods and main results [Figure: see text] RESULTS: In this study, we found that 30% of Enterobacter clinical strains causing bloodstream infections at West China Hospital exhibited CHR, which was associated with treatment failure and fatal infections, as demonstrated by in vitro time-kill tests and in vivo mouse infection modeling. We identified base alterations in the phoP-phoQ gene as the main resistance mechanism in Enterobacter CHR and that this heterogeneity originated from colistin selection and base heterozygosity, as detected by ultra-deep second-generation sequencing. We also found that several different resistance subpopulations existed simultaneously in the same strain with different resistance mechanisms. Time-kill experiments in Enterobacter isolates with CHR or susceptible to colistin [Figure: see text] CHR strains lead to in vivo colistin treatment failure [Figure: see text] Phenotypic and genomic study of a CHR strain [Figure: see text] CONCLUSION: We presented evidence for "genetic heterogeneity" in Enterobacter CHR strains, which is consistent with "phenotypic heterogeneity" and genetically explains the unstable and transient HR. This provides important insights and a fresh perspective into the mechanisms and clinical implications of Enterobacter CHR and underscores the importance of deep sequencing, prompting the research of high-throughput microbial single-cell sequencing as a method for detecting "genetic heterogeneity." Frequency of bases that mediate colistin resistance at the same locus of phoP-Q in the parental and resistant strains [Figure: see text] DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-10678721 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-106787212023-11-27 2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations Wang, Chengcheng Feng, Yu Zong, Zhiyong Open Forum Infect Dis Abstract BACKGROUND: Enterobacter species are major nosocomial pathogens, and the clinical implications and mechanisms of colistin heteroresistance (CHR) in Enterobacter remain unclear. METHODS: We used the population analysis profile (PAP) assay to determine the presence of CHR in Enterobacter. To examine whether CHR leads to treatment failure, we conducted in vitro time-killing assays and in vivo assays using murine intra-abdominal infection models. To determine the genetic mechanism for the CHR phenotype, we conducted whole-genome sequencing and ultra-deep second-generation sequencing. A schematic outline of methods and main results [Figure: see text] RESULTS: In this study, we found that 30% of Enterobacter clinical strains causing bloodstream infections at West China Hospital exhibited CHR, which was associated with treatment failure and fatal infections, as demonstrated by in vitro time-kill tests and in vivo mouse infection modeling. We identified base alterations in the phoP-phoQ gene as the main resistance mechanism in Enterobacter CHR and that this heterogeneity originated from colistin selection and base heterozygosity, as detected by ultra-deep second-generation sequencing. We also found that several different resistance subpopulations existed simultaneously in the same strain with different resistance mechanisms. Time-kill experiments in Enterobacter isolates with CHR or susceptible to colistin [Figure: see text] CHR strains lead to in vivo colistin treatment failure [Figure: see text] Phenotypic and genomic study of a CHR strain [Figure: see text] CONCLUSION: We presented evidence for "genetic heterogeneity" in Enterobacter CHR strains, which is consistent with "phenotypic heterogeneity" and genetically explains the unstable and transient HR. This provides important insights and a fresh perspective into the mechanisms and clinical implications of Enterobacter CHR and underscores the importance of deep sequencing, prompting the research of high-throughput microbial single-cell sequencing as a method for detecting "genetic heterogeneity." Frequency of bases that mediate colistin resistance at the same locus of phoP-Q in the parental and resistant strains [Figure: see text] DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10678721/ http://dx.doi.org/10.1093/ofid/ofad500.1811 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Wang, Chengcheng Feng, Yu Zong, Zhiyong 2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations |
title | 2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations |
title_full | 2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations |
title_fullStr | 2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations |
title_full_unstemmed | 2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations |
title_short | 2189. Colistin Heteroresistance in Enterobacter due to Base Heterozygosity at Certain phoPQ Locations |
title_sort | 2189. colistin heteroresistance in enterobacter due to base heterozygosity at certain phopq locations |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678721/ http://dx.doi.org/10.1093/ofid/ofad500.1811 |
work_keys_str_mv | AT wangchengcheng 2189colistinheteroresistanceinenterobacterduetobaseheterozygosityatcertainphopqlocations AT fengyu 2189colistinheteroresistanceinenterobacterduetobaseheterozygosityatcertainphopqlocations AT zongzhiyong 2189colistinheteroresistanceinenterobacterduetobaseheterozygosityatcertainphopqlocations |